150
Participants
Start Date
July 18, 2023
Primary Completion Date
February 28, 2030
Study Completion Date
February 28, 2030
Methotrexate
Methotrexate is vibrant yellow-orange colored powder with physical properties of near insolubility in water formulated into methotrexate tablets containing an amount of methotrexate sodium equivalent to 2.5 mg of methotrexate and are round, convex, and yellow. The chemical name is N-\[4-\[\[(2,4-diamino-6pteridinyl)methyl\]methyl amino\]benzoyl\]-L-glutamic acid. Methotrexate is an anti-metabolite that is a folate antagonist that inhibits lymphocyte proliferation and functions as an immunosuppressant in arthritis.
Placebo
Placebo
Clinica de la Costa, Barranquilla
George Washington University
OTHER